(SAGE) Sage Therapeutic - Performance -17.3% in 12m
SAGE performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-74.56%
#113 in Peer-Group
Rel. Strength
25.44%
#5538 in Stock-Universe
Total Return 12m
-17.32%
#75 in Peer-Group
Total Return 5y
-78.80%
#89 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 13.08 USD |
| 52 Week Low | 4.78 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 90.94 |
| Buy/Sell Signal +-5 | -1.43 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SAGE (-17.3%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: SAGE vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SAGE
| Total Return (including Dividends) | SAGE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 37.76% | 2.09% | 4.55% |
| 3 Months | 14.72% | 2.27% | 10.78% |
| 12 Months | -17.32% | -10.84% | 14.71% |
| 5 Years | -78.80% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | SAGE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 84.5% | 18.8% | 79.2% |
| 3 Months | 3.6% | 71.5% | 92.9% |
| 12 Months | -28.3% | -84.3% | 44.2% |
| 5 Years | -88.1% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th95.50 | 34.95% | 31.77% |
| 3 Month | %th64.50 | 12.18% | 3.55% |
| 12 Month | %th63.00 | -7.27% | -27.92% |
| 5 Years | %th56.00 | -71.25% | -90.02% |
FAQs
Does Sage Therapeutic (SAGE) outperform the market?
No,
over the last 12 months SAGE made -17.32%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months SAGE made 14.72%, while XBI made 2.27%.
Performance Comparison SAGE vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SAGE vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.9% | 33.2% | 61.9% | -32% |
| US NASDAQ 100 | QQQ | -5.7% | 32.2% | 59.8% | -32% |
| German DAX 40 | DAX | -4.7% | 37.8% | 49% | -47% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.6% | 33.6% | 63.9% | -35% |
| Hongkong Hang Seng | HSI | -4.5% | 32% | 46.2% | -53% |
| India NIFTY 50 | INDA | -4.5% | 35.7% | 62.2% | -17% |
| Brasil Bovespa | EWZ | -6.2% | 30% | 37.4% | -31% |
SAGE vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.4% | 31% | 55.3% | -46% |
| Consumer Discretionary | XLY | -3.3% | 36.1% | 70.6% | -37% |
| Consumer Staples | XLP | -1.4% | 39.4% | 63.7% | -27% |
| Energy | XLE | -0.5% | 34.3% | 67.4% | -13% |
| Financial | XLF | -5% | 34.7% | 58.8% | -46% |
| Health Care | XLV | -3.9% | 35.7% | 69.1% | -12% |
| Industrial | XLI | -4.5% | 34% | 55.3% | -41% |
| Materials | XLB | -2.9% | 36.1% | 62.6% | -20% |
| Real Estate | XLRE | -0.4% | 37.8% | 64.5% | -30% |
| Technology | XLK | -6.2% | 28.9% | 58.7% | -29% |
| Utilities | XLU | -2.5% | 37.7% | 58.6% | -42% |
| Aerospace & Defense | XAR | -6.8% | 27.9% | 40.5% | -70% |
| Biotech | XBI | -2.7% | 35.7% | 75.9% | -6% |
| Homebuilder | XHB | -3.1% | 31.7% | 73.2% | -18% |
| Retail | XRT | -1.8% | 36.4% | 70.6% | -23% |
SAGE vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.4% | 32.6% | 71.2% | -7% |
| Natural Gas | UNG | 7.3% | 47.2% | 77.1% | -10% |
| Gold | GLD | 0.1% | 40% | 42.1% | -59% |
| Silver | SLV | -1.5% | 33.9% | 43.4% | -40% |
| Copper | CPER | -5.2% | 33.6% | 42.2% | -33% |
SAGE vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -3.7% | 34.1% | 65.1% | -19% |
| iShares High Yield Corp. Bond | HYG | -2.8% | 35.9% | 62.9% | -28% |